Welcome to the Clinical Trials Office
As you consider treatment options for yourself or your loved one, you may consider participation in a clinical trial. The resources below provide general and specific information that can help you navigate the clinical trial process.
Current Clinical Trials
Below is a list of enrolling clinical trials at MaineHealth. Studies can open and close quickly so please contact the Clinical Trials Office directly or speak with your healthcare professional if you are interested in learning more about one of the trials. You can reach the Clinical Trials Office at 207-396-8670 or email at clinicalresearch@mainehealth.org.
For a complete list of trials open in the U.S. and abroad, visit www.clinicaltrials.gov.
(POTS) Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain Learn more
(Regional BKA) A Prospective, Randomized Trial of Liposomal Bupivacaine Compared to Continuous Nerve Catheters on Pain Control and Post-Operative Opioid Use in Receiving Popliteal Nerve Blocks for Below the Knee Amputation Learn more
(ATHN 8: PUPs Matter Study) US Cohort Study of Previously Untreated Patients (PUPs) With Congenital Hemophilia Learn more
(A011801/ COMPASSHER2) The CompassHER2 Trials (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer) CompassHER2 Residual Disease (RD), a Double-Blinded, Phase III Randomized Trial of T-DM1 Compared With T-DM1 and Tucatinib Learn more
(A211801/ BRCA-P) A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase 3 Study to Determine the Preventive Effect of Denosumab on Breast Cancer in Women Carrying a BRCA1 Germline Mutation Learn more
(CCTG MA.39) TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer Learn more
(NOHA in BRCA) A Pilot Study of NOHA levels in BRCA positive Breast Cancer
(NOHA in TNBC) A Pilot Study of NOHA as a monitoring biomarker in triple negative breast cancer (TNBC)
(cHOD17) Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 Learn more
(COG AALL1621) A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL) Learn more
(COG AALL1631) International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones Learn more
(COG AALL1731) A Phase 3 Trial Investigating Blinatumomab ( NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy) Learn more
(COG AALL1732) A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-Lly Learn more
(COG AAML18P1) Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia – Chronic Phase (CML-CP) Learn more
(COG ACCL1931) A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy Learn more
(COG ACCL2031) A Phase 3 Randomized, Placebo-Controlled Trial Evaluating Memantine for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy as Part of Treatment for Primary Central Nervous System Tumors Learn more
(COG ACCL21C2) Prospective Cohort Study to Evaluate Immunologic Response Following COVID-19 Vaccination in Children, Adolescents and Young Adults With Cancer Learn more
(COG ACNS1831) A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG) Learn More
(COG ACNS1833) A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine Versus Selumetinib (NSC# 748727) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) Not Associated With BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1) Learn more
(COG ACNS1931) A Phase 3 Study of Selumetinib (NSC# 748727) or Selumetinib in Combination With Vinblastine for Non-NF1, Non-TSC Patients With Recurrent or Progressive Low-Grade Gliomas (LGGs) Lacking BRAFV600E or IDH1 Mutations Learn more
(COG ACNS2021) A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor Learn more
(COG AGCT1531) A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors Learn more
(COG ALTE11C2) Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy Learn more
(COG ANHL1931) A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma Learn more
(COG AOST2031) Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma Learn more
(COG APAL2020SC) Pediatric Acute Leukemia (PedAL) Screening Trial – Developing New Therapies for Relapsed Leukemias Learn more
(COG APEC14B1) Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study Learn more
(COG APEC1621SC/ COG MATCH) COG Pediatric Molecular Analysis for Therapy Choice Screening Protocol Learn more
(COG AREN03B2) Renal Tumors Classification, Biology, and Banking Study Learn more
(COG AREN1921) Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT) Learn more
(COG ARST2031) A Randomized Phase 3 Trial of Vinorelbine, Dactinomycin, and Cyclophosphamide (VINO-AC) Plus Maintenance Chemotherapy With Vinorelbine and Oral Cyclophosphamide (VINO-CPO) vs Vincristine, Dactinomycin and Cyclophosphamide (VAC) Plus VINO-CPO Maintenance in Patients With High Risk Rhabdomyosarcoma (HR-RMS) Learn more
(COG ARST2032) A Prospective Phase 3 Study of Patients With Newly Diagnosed Very Low-Risk and Low-Risk Fusion Negative Rhabdomyosarcoma Learn more
(DFCI 20-302 [Leukemia Profiling]) Protocol for genomically profiling, collecting, archiving and distributing blood and bone marrow specimens from children and young adults with hematologic malignancy. Learn more
(TPX-0005) A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, And Anti-Tumor Activity Study Of Repotrectinib In Pediatric And Young Adult Subjects With Advanced Or Metastatic Malignancies Harboring ALK, ROS1, or NTRK1-3 Alterations Learn more
(A221805) Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer Learn more
(EA2182/ DECREASE) A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE) Learn more
(NRG-CC005/ FORTE) Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps Learn more
(NRG-GI008/ CIRCULATE) Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US) Learn more
(A092104) A Randomized Phase 2/3 Study of Olaparib Plus Temozolomide Versus Investigator’s Choice for the Treatment of Patients With Advanced Uterine Leiomyosarcoma After Progression on Prior Chemotherapy Learn more
(NRG-GU010/ GUIDANCE) Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE) Learn more
(S1802) Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer Learn more
(AFT-50/ ENDOMAP) A Phase IB/II Multi-Cohort Study of Targeted Agents and/or Immunotherapy With Atezolizumab for Patients With Recurrent or Persistent Endometrial Cancer Learn more
(AOA-PRT-0001) Collection and Banking of Blood Samples for the Study of Female Gynecological Diseases
(EAY191/ ComboMATCH) Molecular Analysis for Combination Therapy Choice (ComboMATCH) Learn more
(GOG-3043/ ROCC) A Phase III Randomized Controlled Trial of Robotic Versus Open Radical Hysterectomy for Cervical Cancer (ROCC) Learn more
(GOG-3078/ GLORIOSA) Randomized, Multicenter, Open-label, Phase 3 Study of Mirvetuximab Soravtansine in Combination With Bevacizumab Versus Bevacizumab Alone as Maintenance Therapy for Patients With FRa-positive Recurrent Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers Who Have Not Progressed After Second Line Platinum-based Chemotherapy Plus Bevacizumab Learn more
(NRG-CC008/ SOROCk) A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers Learn more
(NRG-GY019) A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum Learn more
(NRG- GY026) A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined With Either Trastuzumab and Hyaluronidase-Oysk (HERCEPTIN HYLECTA) or Pertuzumab, Trastuzumab, and Hyaluronidase-Zzxf (PHESGO) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma Learn more
(NRG-GY033) A Phase II Study of Androgen Receptor (AR) Inhibition by Darolutamide in Combination with Leuprolide Acetate and Exemestane in Recurrent Adult-Type Ovarian Granulosa Cell Tumor Learn more
(TSR 3000-02-05/ OPAL) Phase 1B/2 Multicohort Umbrella Study to Evaluate the Safety and Efficacy of Novel Treatments and/or Combinations of Treatments in Participants with Ovarian Cancer Cohort C: Open-label Phase 2, Randomized, Controlled Multicenter Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants with Homologous Recombination-Deficient Stage III/IV Ovarian Cancer Learn more
(NRG-BN003) Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma Learn more
(ON-TRK) ON-TRK: PrOspective Non-interventional study in patients with locally advanced or metastatic TRK fusion cancer treated with larotrectinib Learn more
(PROSPECT/ ONO-4059) An open-label phase II study to investigate the efficacy, safety, and pharmacokinetics of tirabrutinib in patients with Primary Central Nervous System Lymphoma (PCNSL) Learn more
(10323/ Moonshot BioBank) Cancer Moonshot Biobank Learn more
(A031704/ PDIGREE) PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated Renal Cell Cancer [PDIGREE] Learn more
(Cardio-Surveillance) Cardio-surveillance of MHCCN Cancer Patients Undergoing Immune Checkpoint Blockade
(DCP-001) Use of a Clinical Trial Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)
(EA8184/ Green Tea Study) A Phase II Randomized Double Blinded Study of Green Tea Catechins (GTC) vs. Placebo in Men on Active Surveillance for Prostate Cancer: Modulation of Biological and Clinical Intermediate Biomarkers Learn more
(EA8192) A Phase II/III Trial of MEDI4736 (Durvalumab) and Chemotherapy for Patients With High Grade Upper Tract Urothelial Cancer Prior to Nephroureterectomy Learn more
(EA8212/ BRIDGE) A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE) Learn more
(NRG-HN005) A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients with Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer Learn more
(KRAS G12C) A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (KRYSTAL-1) Learn more
(NHLBI-MDS) The National Myelodysplastic Syndromes Natural History Study Learn more
(NRG-GU009/PREDICT-RT) Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*) Learn more
(NRG-HN009) Randomized Phase II/III Trial of Radiation With High-Dose Cisplatin (100 mg/m2) Every Three Weeks Versus Radiation With Low-Dose Weekly Cisplatin (40 mg/m2) for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) Learn more
(S1912CD/ CREDIT) A Randomized Trial Addressing Cancer-Related Financial Hardship Through Delivery of a Proactive Financial Navigation Intervention (CREDIT) Learn more
(SIMPRO) SIMPRO Research Center: Integration and Implementation of PROs for Symptom Management in Oncology Practice Learn more
(TAPUR) TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer (TAPUR) Learn more
(WF-1805CD/ HN-STAR) Implementation and Effectiveness Trial of HN-STAR (HN-STAR) Learn more
(WF-1901/ IMPACTS) Internet-delivered Management of Pain Among Cancer Treatment Survivors Learn more
(A081801/ Alchemist Chemo-IO) Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, ALCHEMIST Chemo-IO Study Learn more
(A082002) A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy With or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer Learn more
(A151216/Alchemist Screening) Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST) Learn more
(E4512/Alchemist Treatment) A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein Learn more
(LUNGMAP) A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study) Learn more
(NRG-LU007/ RAPTOR) RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial Learn more
(CRYPTICS) Randomized Controlled Trial Comparing Dimethyl Sulfoxide Cryopreserved Platelets to Liquid Stored Platelets in Patients Undergoing Cardiopulmonary Bypass Surgery Learn more
(PACES) Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after CABG Learn more
(PRIMARY) Percutaneous or Surgical Mitral Valve Repair Learn more
(ACS FcGammaRila) Assessment of Individual Risk of Cardiovascular Events by Platelet FcGammaRila Learn more
(ATRIUM) AbatacepT foR ImmUne checkpoint inhibitor associated Myocarditis Learn more
(EMPRO) Embolic Protection in Patients Undergoing High-Risk Valve Surgery Learn more
(FINEARTS-HF) A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction =40% (LVEF =40%) Learn more
(Maternal Hyperoxia) Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association with Neonatal Neurobehavior
(PACCS) Pulmonary Artery Catheter in Cardiogenic Shock Trial Learn more
(Philips Ultrasound) Philips Ultrasound Study Protocol – Maine Medical Center
(REACT-AF Registry) Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Learn more
(REAL AF Registry) Real-world Experience of Catheter Ablation for the Treatment of Symptomatic Paroxysmal and Persistent Atrial Fibrillation Using Novel Contact Force Technologies: REAL AF Registry Learn more
(Short Cut) Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease-A Randomized Controlled Trial
(RECOVER) NIH RECOVER: A Multi-site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults Learn more
(BOOST3) Brain Oxygen Optimization in Severe Traumatic Brain Injury—Phase 3 Learn more
(ICECAP) Influence of Cooling duration on Efficacy in Cardiac Arrest Patients Learn more
(PCAS) Inter-individual variables associated with neurological outcomes in Post Cardiac Arrest Syndrome Learn more
(PRECICECAP) A multicenter, observational substudy to the ICECAP trial to define patterns of post-arrest injury (phenotypes) that predict optimal duration of induced hypothermia after cardiac arrest Learn more
(REASSESS ICH) Repeated Assessment of Survivors in Intracerebral Hemorrhage Study Learn more
(Elevating Remote CF Care [Nudge]) Elevating Remote Cystic Fibrosis Care (Nudge App)
(STOP360) Standardizing Treatments for Pulmonary Exacerbations: A platform for evaluating treatment decisions to improve outcomes (STOP360)
N/A
(ED-INNOVATION) Emergency Department-Initiated Buprenorphine Validation Network Trial
N/A
(Enhance [HELP]) Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders Learn more
(ATHN 10) Leveraging the ATHNdataset to Document the State of Rare Coagulation Disorders in the United States
(ATHN – Transcends) A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment in People with Non-Neoplastic Hematologic Disorders Learn more
(Community Counts) CDC Public Health Surveillance for Bleeding Disorders – Registry for Bleeding Disorders Surveillance
(Immulina) Effect of Immulina Supplements on Inflammatory Biomarkers Correlated with Clinical Symptoms in Patients with Long COVID (PASC) Learn more
(Promis) Pathobiology in RECOVER Of Metabolic and Immune Systems (PROMIS). **For RECOVER participants only**
(RECOVER) NIH RECOVER: A Multi-site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults Learn more
N/A
(ALZ-NET) Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET) Learn more
(HEP3) Human Epilepsy Project 3: Newly Diagnosed Idiopathic Generalized Epilepsy Learn more
(TEMPO-1) A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, 27-Week Trial To Evaluate The Efficacy, Safety, And Tolerability Of Two Fixed Doses Of Tavapadon In Early Parkinson’S Disease (TEMP0-1 Trial) Learn more
(TEMPO-4) 58-Week Open Label Trial of TAVAPADON In PARKINSON’S Disease (TEMPo-4 TRIAL) Learn more
(X-TOLE2) Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures Learn more
(ATTACC-CAP) AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia Learn More
(HOTLaser) Comparison of Lumenis Pulse 120H Moses 2.0 holmium laser versus Olympus Soltive thulium fiber laser for mini-percutaneous nephrolithotomy Learn more
(INDV-6000-406) A Phase IV Longitudinal Study of SUBLOCADE (SUBUTEX Prolonged Release) Clinical Outcomes in Adults with Opioid Use Disorder (Opioid Dependence) Learn More
(INDV-600-407) A Phase IV Study to Evaluate the SUBLOCADE Treatment Exit Strategy Learn More
(PE-TRACT) Pulmonary Embolism – Thrombus Removal With Catheter-Directed Therapy Learn more
(CREST 2) Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial Learn more
(CREST-H) Carotid Revascularization and Medical Management for Asymptomatic Carotid stenosis – Hemodynamics (CREST-H) Learn more
(STERLING Registry) A Prospective, Multi-Center, Single Arm Study To Obtain “Real World” Clinical Data And Characterize The Acute And Long-Term Performance Of The Micrusframe And Galaxy Coils For The Endovascular Treatment Of Intracranial Aneurysms Learn more
(ACCQUIREnet) Allied Cleft & Craniofacial Quality-Improvement and Research Network (ACCQUIREnet): Prospective Data-collection System and Learning Health-care Network for the Comprehensive Appraisal of Cleft and Craniofacial Care Learn more
(AWARE) Efficacy of Pharmacologic Management of ADHD in Children and Youth with Autism Spectrum Disorder
N/A
N/A
(Stop/Continue Study) A Prospective, Randomized Trial of the Effect of Buprenorphine Continuation on Pain Control and Post-Operative Opioid Use Learn more
(ADVANCE) EndurAnt Stent Graft system vs ExcluDer endoprothesis: a global, prospectiVe, rANdomized Clinical trial in sac rEgression (ADVANCE) Learn more
(CREST 2) Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial Learn more
(CREST-H) Carotid Revascularization and Medical Management for Asymptomatic Carotid stenosis – Hemodynamics (CREST-H) Learn more
(Roadster 3) Post-Approval Study Of Transcarotid Artery Revascularization In Standard Risk Patients With Significant Carotid Artery Disease (The Roadster 3 Study) Learn more
(APO Study) Beta 1-Selective Blockade for Prevention of Postmenopausal Bone Loss: A Phase 3, Multi-Center, Double-Blinded, Randomized Placebo-Controlled Trail Learn more
RESOURCES
Learn More About Clinical Trials
Clinical Research Brochure:
Why Participate in Research?
Participating in Research
Video Series
ClinicalTrials.Gov
BioBank: Learn About Tissue Donation
Next Step for Providers
Complete our referral form to connect a patient with our oncology clinical trials program.
Next Step for Patients
Complete our patient referral form to learn more about our clinical trials program.
The MaineHealth Cancer Care Network was awarded a grant by the National Cancer Institute (NCI), as a member of the NCI Community Oncology Research Program (NCORP), to implement a new cancer research program that aims to reach more Mainers in their own cities and towns, ensuring they have access to the best possible patient care, including access to more advanced clinical trials in their home communities. If you are a patient and thinking about joining a clinical trial, talk to your doctor first. If you are a provider and would like more information about NCORP, please contact the Clinical Trials Office (contact information below).
